These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3433718)

  • 21. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflexal V--the influenza vaccine with the lowest ovalbumin content.
    Kürsteiner O; Moser C; Lazar H; Durrer P
    Vaccine; 2006 Nov; 24(44-46):6632-5. PubMed ID: 16828206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and effectiveness study of the aerosol method of administering inactivated influenza chromatographic vaccine in an experiment].
    Bichurina MA; Briantseva EA; Rozaeva NR; Titova TS; Korovina GI
    Vopr Virusol; 1984; 29(5):527-30. PubMed ID: 6516324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies on pertussis vaccine batches inactivated with glutaraldehyde, beta-propiolactone, formaldehyde or thiomersal.
    Andreescu V; Caffé I; Marion M; Ivan I; David C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):299-308. PubMed ID: 122592
    [No Abstract]   [Full Text] [Related]  

  • 25. [The identification of intestinal parasite stages using the merthiolate-iodine-formalin concentration method (MIF-method)].
    Müller WA; Beer F
    Z Med Lab Diagn; 1979 Feb; 20(1):51-5. PubMed ID: 572116
    [No Abstract]   [Full Text] [Related]  

  • 26. Merthiolate iodine formaldehyde technique for cryptosporidium.
    Caselli M; Libanore M; Ghinelli F; Bicocchi R; Ricci N
    Boll Ist Sieroter Milan; 1987; 66(2):161-2. PubMed ID: 2444236
    [No Abstract]   [Full Text] [Related]  

  • 27. Merthiolate iodine formaldehyde test for detection of intestinal parasites.
    Bhandari B; Gupta AP; Maheshwari CP
    Indian Pediatr; 1984 Oct; 21(10):803-6. PubMed ID: 6526489
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitizing activity to egg protein of an A1PO4-adjuvant full-virus influenza vaccine.
    Nyerges G; Marton A; Korossy S; Vincze I
    Acta Microbiol Acad Sci Hung; 1982; 29(4):245-53. PubMed ID: 7185267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunogenicity of inactivated subunit adsorbed monovalent vaccine against influenza A/California/7/2009 (H1N1) strain].
    Zverev VV; Kostinov MP; Mikhailova NA; Zhirova SN; Mironov AN; Terkacheva OA; Romanova AA; Cherdantsev AP
    Vopr Virusol; 2011; 56(3):20-3. PubMed ID: 21786622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A generalized reaction to thimerosal from an influenza vaccine.
    Lee-Wong M; Resnick D; Chong K
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):90-4. PubMed ID: 15702823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactions to merthiolate in infants.
    Novák M; Kvicalová E; Friedländerová B
    Contact Dermatitis; 1986 Nov; 15(5):309-10. PubMed ID: 3816201
    [No Abstract]   [Full Text] [Related]  

  • 32. Thimerosal: an ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity.
    Cai F; Backman HA; Baines MG
    Curr Eye Res; 1988 Apr; 7(4):341-51. PubMed ID: 3371072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactions to thimerosal in hepatitis B vaccines.
    Rietschel RL; Adams RM
    Dermatol Clin; 1990 Jan; 8(1):161-4. PubMed ID: 2137393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Of vaccine-autism, thimerosal, and metallothioneins.
    Guzzi G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):88; author reply 89. PubMed ID: 17295805
    [No Abstract]   [Full Text] [Related]  

  • 35. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction.
    Zheng W; Dreskin SC
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):574-5. PubMed ID: 18219843
    [No Abstract]   [Full Text] [Related]  

  • 36. Egg-allergic patients can be safely vaccinated against influenza.
    Des Roches A; Paradis L; Gagnon R; Lemire C; Bégin P; Carr S; Chan ES; Paradis J; Frenette L; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2012 Nov; 130(5):1213-1216.e1. PubMed ID: 23021881
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biological properties of live and inactivated influenza vaccines under experimental conditions].
    Bozhenko LV; Agafonova LM; Konstantinova II; Shefer LF; Kustikova IuG
    Vopr Virusol; 1983; (2):187-91. PubMed ID: 6868558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interference of thimerosal in the bicinchoninic acid protein microassay.
    Chattaraj SC; Das SK
    Boll Chim Farm; 2000; 139(1):30-3. PubMed ID: 10829550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.
    Chauvat A; Benhamouda N; Loison E; Gougeon ML; Gey A; Levionnois E; Ravel P; Abitbol V; Roncelin S; Marcheteau E; Quintin-Colonna F; Fridman WH; Launay O; Tartour E
    J Immunol Methods; 2012 Apr; 378(1-2):81-7. PubMed ID: 22366633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.